Changes in the Expression of the Alzheimer's Disease-Associated Presenilin Gene in Drosophila Heart Leads to Cardiac Dysfunction by Li, A. et al.
Changes in the Expression of the Alzheimer’s Disease-
Associated Presenilin Gene in Drosophila Heart Leads to
Cardiac Dysfunction
A. Li1, C. Zhou2, J. Moore1, P. Zhang3, T.-H. Tsai2, H.-C. Lee2, D.M. Romano1, M.L. McKee4,
D.A. Schoenfeld5, M.J. Serra3, K. Raygor1, H.F. Cantiello3, J.G. Fujimoto2,*, and R.E. Tanzi1,*
1 Genetics and Aging Research Unit, Department of Neurology, MassGeneral Institute for
Neurodegenerative Diseases, Massachusetts General Hospital and Harvard Medical School, MA,
USA
2 Department of Electrical Engineering and Computer Science, Massachusetts Institute of
Technology, MA USA
3 Department of Medicine, Massachusetts General Hospital and Harvard Medical School, MA;
USA
4 Program in Membrane Biology, Massachusetts General Hospital and Harvard Medical School,
MA, USA
5 Department of Biostatistics, Harvard School of Public Health, MA, USA
Abstract
Mutations in the presenilin genes cause the majority of early-onset familial Alzheimer’s disease.
Recently, presenilin mutations have been identified in patients with dilated cardiomyopathy
(DCM), a common cause of heart failure and the most prevalent diagnosis in cardiac
transplantation patients. However, the molecular mechanisms, by which presenilin mutations lead
to either AD or DCM, are not yet understood. We have employed transgenic Drosophila models
and optical coherence tomography imaging technology to analyze cardiac function in live adult
Drosophila. Silencing of Drosophila ortholog of presenilins (dPsn) led to significantly reduced
heart rate and remarkably age-dependent increase in end-diastolic vertical dimensions. In contrast,
overexpression of dPsn increased heart rate. Either overexpression or silencing of dPsn resulted in
irregular heartbeat rhythms accompanied by cardiomyofibril defects and mitochondrial
impairment. The calcium channel receptor activities in cardiac cells were quantitatively
determined via real-time RT-PCR. Silencing of dPsn elevated dIP3R expression, and reduced
dSERCA expression; overexprerssion of dPsn led to reduced dRyR expression. Moreover,
overexpression of dPsn in wing disc resulted in loss of wing phenotype and reduced expression of
wingless. Our data provide novel evidence that changes in presenilin level leads to cardiac
dysfunction, owing to aberrant calcium channel receptor activities and disrupted Wnt signaling
transduction, indicating a pathogenic role for presenilin mutations in DCM pathogenesis.
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INTRODUCTION
Alzheimer disease (AD) is a progressive neurodegenerative disorder and the most common
form of dementia in the elderly, affecting one in 10 individuals over 65 and nearly half over
85 years old (http://www.alz.org/). The presenilin 1 and 2 genes (PSEN1 and PSEN2)
encode highly conserved polytopic membrane proteins (PS1 and PS2) that are required for
γ-secretase activity [1]. Mutations in presenilins underlie the majority of cases of early-onset
familial AD. Most mutations in presenilins increase the relative ratio between the longer
(Aβ42) and shorter (Aβ40) amyloid peptides (Aβ42/Aβ40) [2]. Aβ42 is the main component
of amyloid plaques in the brains of AD patients, and the progressive formation of amyloid
plaques is regarded as a key neuropathological feature of AD [3]. Recently, mutations in
presenilins have also been reported in dilated cardiomyopathy (DCM) patients [4, 5],
indicative of allelic heterogeneity. DCM is defined clinically by dilation and impaired
contraction of one or both ventricles. DCM occurs in all ages, most common between 20–60
years. DCM causes roughly one-third of cases of congestive heart failure and is the most
prevalent diagnosis in individuals referred for cardiac transplantation. Half of DCM patients
die within 15 years after diagnosis [6]. Presenilin mutations were identified in DCM patients
in the PSEN1 5′ promoter and a large cytoplasmic loop between transmembrane domains six
and seven, and PSEN2 NH2 terminus [4, 5]. Presenilin mutations have also commonly been
found in 20% of severe DCM patients who required heart transplantation due to heart failure
[5]. The PSEN1 5′ promoter region variants in DCM patients led to significant reduction in
transcriptional activities and decreased expression of PS1 protein in the myocardium [5].
The PSEN2-R62H missense mutation in DCM patients enhanced PS2 degradation, reduced
PS2 stability in mouse embryonic fibroblasts, and altered compromised PS2 function in
Notch signaling in C. elegans [7]. Together, these data suggest that PSEN1 and PSEN2
mutations or variants contribute to DCM pathogenesis through loss of gene function, and
implicate novel mechanisms of cardiomyopathy.
Both AD and DCM are associated with high morbidity and mortality, but currently have no
cure. The molecular mechanisms by which presenilin mutations lead to DCM pathogenesis
are not yet understood. AD brain contains Aβ oligomers, which have been shown to impair
neurotransmission [8]. Likewise, amyloid oligomers have been found in the failing heart of
DCM patients associated with cardiomyocyte apoptosis [5], in cardiomyocytes derived from
human heart-failure patients, and in mice model of desmin-related cardiomyopathy [9].
Protein misfolding is implicated in the etiology and pathogenesis of both AD and DCM [5].
Apolipoprotein E (APOE) is a multifunctional protein that plays a key role in the
metabolism of cholesterol and triglycerides; APOE gene ε4 variant is not only the largest
known genetic risk factor for late-onset AD [10], but also increases both low-density
lipoprotein cholesterol level and coronary heart disease risk [11]. Moreover, cerebral
angiopathy contributes to cognitive decline and dementia in AD patients and mouse models
[12]. The expression of vascular MEOX2 is low in AD; silencing of MEOX2 in brain
capillaries results in aberrant brain angiogenesis, reduced vascular density and faulty
clearance of Aβ [13]. These indicate the connection between AD and cardiovascular
diseases.
PSEN1 and PSEN2 are strongly expressed in the heart and essential for cardiac
morphogenesis [14, 15]. To date, there is no reported information regarding the in vivo
functional role of PS1 in adult heart. Mice null for Ps1 are either dead at birth (Ps1−/−) or
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embryonically lethal (Ps1−/−/Ps2−/+), exhibiting multiple developmental defects including a
cardiac anomaly [15]. The basic mechanisms of heart development and control of cardiac
function are highly conserved between human and Drosophila melanogaster, or the fruit fly,
which has been successfully used to characterize genes associated with human diseases,
including cardiomyopathy [16, 17]. Moreover, the morphological and rhythm changes can
be readily analyzed in the relatively simple organization of fly heart with an emerging
medical imaging technology optical coherence tomography (OCT) [16, 18, 19]. OCT
enables real-time, in vivo, micron-scale and three-dimensional imaging of biological tissues
[20]. OCT has been used for a wide range of clinical applications in human, including
ophthalmology, endoscopy, cardiovascular imaging [20–22], and recently, studying cardiac
functions in live Drosophila [23].
The human PSEN1 and PSEN2 are represented by a highly conserved single ortholog, dPsn,
in Drosophila [24, 25]. To better understand the pathogenic role(s) of presenilin mutations
in DCM, we have employed transgenic Drosophila models to analyze the effects of
overexpression or RNAi silencing of dPsn on cardiac function, assessed by employing the
noninvasive OCT technology. In addition, we also examined heart ultrastructure, calcium
channel receptor level, wing development and expression of the wingless (wg) protein, the
central component of Wnt signaling transduction pathway that regulates cardiac
development.
MATERIAL AND METHODS
Transgenic Flies and Fly Culture
Fly culture and crosses were carried out according to standard procedures. The following fly
strains were used: GMR-GAL4 [26, 27], Sd-GAL4 [28], Ptc-GAL4 [29], 24B-GAL4 [30],
2XUAS-dPsn; GMR-GAL4 [25] and UAS-dPsnRNAi [31].
Optical Coherence Tomography (OCT) for Drosophila Cardiac Function Assessment
The OCT system used is modified based on a swept source OCT engine (Thorlabs Inc).
To study the cardiac function, the flies were anesthetized with Fly Nap for 2 minutes and
mounted on glass slides before imaging. Two-dimensional cross-sectional images consisting
64 A-lines covering 250 μm over the heart chamber were continuously acquired for 5
seconds at ~120 fps. The imaging plane was consistently chosen to be within segments A6–
A7 of the Drosophila heart chamber. This OCT system achieved a finer imaging resolution
and significantly improved imaging speed compared to previously reported OCT apparatus
for Drosophila heart imaging [23]. Three to four repeated measurements were acquired for
each fly. The same experimental groups were repeatedly measured and the results were
included in the final data. Post-processing the image data was performed with custom
written Matlab (Math-works, Inc) codes to obtain the dimensions of the heart chamber for
each frame. M-mode image over the center of the chamber was generated together with the
dimension over time. Functional parameters, including heart rate (HR, beat per minute,
BPM), rhythmicity of the heartbeat, and the end-systolic and end-diastolic vertical
dimensions (ESD and EDD, μm) and fraction shorting (FS, %), were extracted from the
dimension plots. The prevalence of arrhythmia was quantitatively analyzed via identifying
irregular heartbeat rhythm in the dimension plots for the number of arrhythmia flies in each
group (%).
Heart Ultrastructure Analysis by Transmission Electron Microscopy
10–15 fly hearts from 30-day-old flies of each genotype group were fixed, embedded,
sectioned and examined as modified from previously in a JEOL JEM 1011 transmission
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electron microscope for ultrastructure analyses [32]. In brief, tissues were fixed in
glutaraldehyde, stained en bloc, dehydrated through a graded series of ethanol and then
embedded in Epon. Thin sections were cut, collected on formvar-coated grids, stained with
uranyl acetate and lead citrate and examined in a JEOL JEM 1011 transmission electron
microscope at 80 KV. Images were collected using an Advanced Microscopy Techniques
digital imaging system.
Immuno-Staining and Western Blot Analyses
The third instar wing discs were fixed, blocked and probed with primary and secondary anti-
bodies accordingly. Wings from adult flies were dissected in isopropanol and mounted in
Canada Balsam mounting medium. Western Blot analyses were performed and repeated at
least twice using protein isolated from 7-day old fly heart and muscle and the intensity of
signals was analyzed using image program Quantity One version 4.6.2. In brief, the levels of
analyzed proteins were normalized using the levels of dActin for loading differences
controls, and quantification in total protein amounts and presented as the percentage of those
in the transgenic flies in comparison with that in controls. The following anti-bodies were
used: Mouse anti-wg antibody (Developmental Studies Hybridoma Bank, 1:1000); the
secondary anti-mouse Alexa 546 (Invitrogen, 1:200); Rabbit-anti-dPsn (Genescript, against
CTF, 1:1000); mouse anti-actin (DSHB; 1:1000).
CDNA synthesis and Real-Time RT-PCR
The cDNAs used for real time RT-PCR were synthesized from total RNA isolated from
heart and muscle of 7-day old adult Drosophila. The cDNA was synthesized using
SUPERSCRIPT Preamplification System for First-Strand cDNA Synthesis (Invitrogen).
Real-time RT-PCR quantification with dIP3R, dRyR, dSERCA or dActin-specific sense and
antisense primers was done on an iCycler (BIORAD) using SYBR Green PCR Core
Reagents (Qiagen) according to the manufacturer’s instructions. House-keeping gene dActin
as internal control was co-amplified under the same PCR conditions. All standards and
unknown samples were run in triplicates per reaction. The fluorescence intensity was
calculated using iCycler software version 3.1. The expressions of dIP3R, dRyR and dSERCA
were given as relative number of copies (%) of mRNA molecules, as calibrated by co-
amplification of dActin. dIP3R, dRyR and dSERCA levels were shown as Mean ± Standard
Deviation (Std) of repeated experiments. p values were calculated by two-tailed Student’s t
test. p<0.05 is defined statistically significant.
Statistical Analyses of Cardiac Function
The cardiac functions, including HR, ESD and EDD and FS, were compared between 7-day
old and 30-day old flies overexpressing or silencing dPsn vs. age-matched controls and
between 7-day old and 30-day old flies of each genotype group. We used a SAS GLM
program for statistical analyses. Results were shown as Mean ± Standard Error (SE). p<0.05
is defined statistically significant (actual p values are shown).
RESULTS
Cardiac Function and Heart Ultrastructure Analysis
We employed the well established UAS-dPsn or UAS-dPsn-RNAi transgenic flies and 24B-
GAL4 driver [30] to overexpress or RNAi silence full-length wild-type (WT) dPsn
specifically in fly heart and muscle [24, 25, 30, 31]. The 24B-GAL4 line allows targeted
expression in mesoderm and all cardiac and muscular cells with a uniform and high level of
expression in the most anterior heart cells [33]. Flies in which dPsn was either
overexpressed or silenced by 24B-GAL4 appeared normal at eclosion. We quantitatively
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measured cardiac function, including heart rate (HR, beat per minute, BPM), rhythmicity of
the heartbeat, the end-systolic and end-diastolic vertical dimensions -ESD and EDD (μm),
fraction shorting (FS, %), in adult flies with a customized OCT system.
We analyzed 7-day and 30-day old adult male flies overexpressing dPsn (UAS-dPsn; 24B-
GAL4) or RNAi silencing dPsn (UAS-dPsnRNAi; 24B-GAL4) in comparison with that of
age-matched male controls (24B-GAL4/+) Fig. (1 & 2) (Table 1). Compared with age-
matched controls, at either 7-day, 30-day old age group alone, or 7-day and 30-day old
combined age group, overexpression of dPsn significantly increased HR; in contrast,
silencing of dPsn significantly decreased HR. Remarkably, either overexpression or RNAi
silencing of dPsn in heart resulted in very irregular heartbeats: heartbeat rhythm changed
rapidly between fast and slow pace within 1–2 seconds, or vice versa. Quantitative analysis
of arrhythmia prevalence demonstrated that silencing of dPsn significantly increased the
number of flies with arrhythmia at 30-day old flies (57%) or combined age group (54%)
compared to that in age-matched control flies. Likewise, overexpression of dPsn resulted in
significant increase in the number of flies with arrhythmia at 30-day old flies (46%)
compared to 7-day old flies (19%). Control flies aging from 7-day to 30-day old barely
changed arrhythmia prevalence (26% to 27%). Overexpression of dPsn decreased ESD at
30-day old flies or combined age group. Flies in which dPsn was silenced showed
significantly reduced ESD (30-day old flies alone and combined age group) and EDD (7-day
old flies and combined age group). Compared with 7-day old flies, 30-day old flies in which
dPsn was silenced exhibited a significant decrease in HR and a remarkable increase in EDD
and FS. 30-day old of flies in which dPsn was overexpressed or control flies also showed a
trend for age-dependent decrease in HR and significant increase in EDD compared with that
in 7-day old flies (Table 1).
Consistent with cardiac function alterations, analysis of heart ultrastructure by transmission
electron microscopy revealed normal myofibril structure in control flies Fig. (3A). In
contrast, myofibrils of heart from flies overexpressing dPsn exhibited irregular structure
with vacuoles, a broadening of Z-line, and swollen mitochondria Fig. (3B). RNAi silencing
of dPsn led to an overall decrease in the density of myofibrils with vacuoles, a breaking Z-
line, and severely degenerative mitochondria with impaired structure Fig. (3C).
To assess the effects of RNAi silencing or overexpression of dPsn in transgenic flies, we
carried out Western blot analysis using protein lysates isolated from the heart and muscle of
7-day old flies Fig. (4). Silencing of dPsn led to a 60% decrease in dPsn expression, and
overexpression of dPsn led to a 180% increase in dPsn expression as compared to controls
Fig. (4).
Calcium Channel Receptor Expression
In cardiac muscle, Ca2+ influx during depolarization of action potential initiates the
sequence of events leading to contraction. Ca2+ signaling is primarily modulated by the
functional properties of Ca2+ release channels. There are two main types of Ca2+ release
channels, the inositol 1,4,5-trisphosphate receptor (IP3R) and the ryanodine receptor (RyR)
[34].
The removal of cytosolic Ca2+ allows for relaxation of muscle fibres. The Ca2+uptake into
sarcoplasmic reticulum (SR) store occurs predominately by the cardiac isoform of the SR
Ca2+-ATPase pump SERCA2a [34]. We have identified that the human IP3R, RyR and
SERCA2a are represented by highly conserved single orthologs in Drosophila, as dIP3R
(Itp-r83A), dRyR (Rya-r44F) and dSERCA (Ca-P60A) (www.flybase.org). We quantitatively
determined the expression of dIP3R, dRyR and dSERCA levels via real-time RT-PCR
amplification of cDNA samples from 7-day old flies in which dPsn was overexpressed
Li et al. Page 5
Curr Alzheimer Res. Author manuscript; available in PMC 2011 October 2.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(UAS-dPsn; 24B-GAL4), or silenced (UAS-dPsnRNAi; 24B-GAL4) and control (24B-
GAL4/+). dIP3R, dRyR and dSERCA levels were normalized by co-amplified internal
control gene dActin. dIP3R expression levels were 1.17 fold higher in flies overexpressing
dPsn, and 2.19-fold higher in flies dPsn was silenced as compared to controls Fig. (5A).
Overexpressing of dPsn led to significantly decreased dRyR expression (60% of control
levels), while silencing of dPsn slightly increased dRyR expression (1.05-fold of control
levels) Fig. (5B). Furthermore, overexpressing of dPsn slightly increased dSERCA
expression (1.1-fold of control levels), and silencing of dPsn significantly decreased
dSERCA expression (40% of control levels) Fig. (5C).
Wing Development and Wingless Expression
The UAS promoter used in the dPsn transgenic models allows for conditional
overexpression or silencing of dPsn with specific GAL4 drivers in the wing or other tissues,
in addition to heart. Drosophila adult wing and thoracic body wall arise from the larval wing
disc. Wing development is regulated by multiple signaling pathways, including Wnt, Notch,
epidermal growth factor receptor, hedgehog and de-capentaplegic. The wing pattern
provides an important tool in isolating and characterizing genes affecting multiple signaling
pathways, e.g. Notch and wg [35]. To assess the potential role of dPsn in wing development,
we ectopically overexpressed or RNAi silenced dPsn in wing disc using two wing-specific
GAL4 drivers, Sd-GAL4 and Ptc-GAL4.
Sd-GAL4 drives the overexpression of dPsn in wing disc in the pattern of scalloped (sd)
gene, which regulates the expression of a number of targeted genes including wg, the central
component of Wnt signaling transduction pathway [28]. Flies in which dPsn was silenced by
RNAi in the wing by the Sd-GAL4 driver were embryonically lethal. Compared with control
flies (Sd-GAL4/+) Fig. (6A), overexpression of dPsn (UAS-dPsn; Sd-GAL4) in wing disc
resulted in the complete loss of both wings, which were consistently observed in over 200
flies in repeated experiments Fig. (6D). We next examined the expression of wg protein by
immunostaining 30 wing discs dissected from the third instar larvae with anti-wg antibody.
wg was expressed as a broad strip in the notum, a thinner strip in the prospective wing
margin-dorsal/ventral (D/V) boundary, and a strip encircling the prospective wing blade in
WT Fig. (6B). Consistent with the phenotype observed in adult flies, there was moderately
decreased wg expression in flies overexpressing dPsn, especially in the prospective wing
blade region Fig. (6E), along with morphological alterations in wing discs. Compared with
control flies Fig. (6C), wing discs of flies overexpressing dPsn were thinner, and reduced in
size, especially in the dorsal/ventral compartment suggesting disc degeneration Fig. (6F).
Together, these data showed that overexpression of dPsn in wing disc by Sd-GAL4 results in
severe wing malformation and reduces wg expression.
Patched (Ptc) is a segment polarity gene that regulates the development of wing
compartments centering at the anterior/posterior border (defined between L3 and L4 vein)
[29]. Compared with control flies Fig. (6G), overexpression of dPsn driven by Ptc-GAL4
resulted in severe loss of intervein cells narrowing the intervein sector between L3 and L4
vein and forming extra vein cells to fill the intervein region. The intervein sector between L4
and L5 was enlarged; and pcv vein was extended Fig. (6H); in contrast, silencing of dPsn
driven by Ptc-GAL4 led to loss of acv vein with normal intervein cells between L3 and L4
vein Fig. (6I). Collectively, these data show that overexpression or silencing of dPsn in wing
disc by Ptc-GAL4 alters wing vein formation.
DISCUSSION
We have found that either overexpression or RNAi silencing of dPsn in Drosophila leads to
significant changes in HR and to an irregular heartbeat rhythm accompanied with
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cardiomyofibril defects. While either overexpression or silencing of dPsn decreased end-
systolic and end-diastolic heart chamber size and increased FS compared to age-matched
controls, flies in which dPsn was silenced exhibited an age-dependent remarkably increase
in EDD and FS. Taken together, these data indicate that overexpression or RNAi silencing
of dPsn in heart primarily leads to irregular heartbeat rhythm via regulating the electrical
activity that stimulates the myocardium of the heart for contraction.
Initiation of cardiac muscle contraction requires an increase in intracellular calcium from
resting concentration. The increase in intracellular calcium then triggers further release of
calcium from SR stores via the Ca2+ release channel receptor RyR. The release of calcium
can be further enhanced by activation of the Ca2+ release channel receptor IP3R. This
“calcium-induced calcium release” process ensures rapid and significant increases in
intracellular calcium, which are essential to contraction [34]. SERCA2a transfers Ca2+ from
the cytosol of the cell to the lumen of the SR during cardiac muscle relaxation [34]. In
cultured fibroblasts from DCM patients with PSEN1-D333G or PSEN2-S130L mutations,
histamine-induced resting intracellular Ca2+ concentrations are elevated [4]. In mouse heart
muscle, Ps1 and Ps2 physically interact and colocalize with both IP3R and the cardiac form
of RyR (RyR2) to SR [36, 37]. In Ps1- and Ps2-deficient mouse embryonic fibroblasts, free
Ca2+ concentrations in SR are decreased and IP3R levels are increased [38]. In neuronal
cells, overexpression of AD-associated PSEN1-M146V or PSEN2-N141I mutants directly
increases IP3R activity [37]. Primary hippocampal neurons from Ps1 mutant knock-in mice
exhibit greatly increased levels of RyR and enhanced Ca2+ release [36]. Sorcin reduces the
open probability of RyR2 [39]. PS2, sorcin, and RyR2 interact with each other in mouse
heart [36]. Ps2- deficient mice develop normally with no evidence of cardiac hypertrophy
and fibrosis, but exhibit increased cardiac contractility and potentiated peak Ca2+ [36].
Elevated Ca2+ attenuates the association of RyR2 with Ps2, and enhances the association of
sorcin with Ps2 [36]. Moreover, PS1 and SERCA2a physically interact and are co-
immunoprecipitated in the myocardium of DCM patients [5]. SERCA activity is diminished
in fibroblasts null for both Ps1 and Ps2. Enhancing presenilin levels in Xenopus laevis
oocytes accelerates clearance of cytosolic Ca2+ by increasing SERCA activity [40]. This
suggests that the presenilins play an important role in cardiac excitation-contraction
coupling and Ca2+ signaling via the interaction between PS2, RyR2 and sorcin, and
regulation of the SERCA pump. Consistent with previous findings, we found that silencing
of dPsn in flies elevated dIP3R expression, and that overexprerssion of dPsn led to reduced
dRyR expression. Silencing of dPsn remarkably reduced dSERCA expression, which
together with degenerated myofibrils may lead to insufficient cardiac muscle relaxation to
reduce the end-systolic and end-diastolic cardiac chamber size. These data thus provide
evidence that presenilins may regulate SR Ca2+ storage or intracellular Ca2+ homeostasis in
cardiac cells.
We found that 30-day old flies exhibited significantly decreased HR, increased heart
chamber size and arrhythmia prevalence compared to 7-day old flies. This is consistent with
previous findings indicating a decline in cardiac function with increasing age in human or
Drosophila [41]. Compared with flies overexpressing dPsn or control flies, flies in which
dPsn was silenced exhibited a more remarkably age-dependent decrease in HR and increase
in EDD and arrhythmia. This indicates that silencing of dPsn more severely exacerbates
age-dependent cardiac dysfunction than does overexpression of dPsn or control flies.
Evidence has shown that the insulin receptor (IR) and associated pathways have a dramatic
and heart-autonomous influence on age-related cardiac performance in flies, suggestive of
potentially similar mechanisms in regulating cardiac aging in vertebrates [41]. IR belongs to
tyrosine kinase receptor family whose activation is essential for insulin signaling in target
tissues. IR undergoes PS/γ-secretase-dependent processing to produce IR intracellular
domain (ICD). PS/γ-secretase inactivation resulted in reduced levels of tyrosine
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autophosphorylation of the IR β-subunit upon insulin stimulation [42]. Moreover, insulin-
like growth factor I receptor (IGF-IR), which shares strong structural homology with IR,
was reported to be a substrate for PS/γ-secretase activity [43]. These data suggest that the
PS/γ-secretase proteolysis of IR may act as a modulator of the insulin signaling pathway.
The heart forms very early during mammalian and avian embryogenesis and arises from
paired mesodermal regions in the embryo. The regulation of Wnt signal transduction has
been implicated as an important event that initiates cardiac development in Drosophila [44].
Wnts are a family of secreted signaling proteins including wg. Presenilin has been
implicated in regulating Wnt signaling. First, presenilin-mediated γ-secretase activity is
required for the intramembranous cleavage of Notch receptor to release notch intracellular
domain (NICD) for the entry to nucleus where it induces the expression of Notch targeted
genes [45]. Loss-of-function dPsn mutants exhibit early embryo lethality and phenotypes
indicative of a general impairment of Notch signaling throughout the development in
Drosophila [24]. This is particularly interesting in view of the fact that there is inhibitory
crosstalk between the Notch and the Wnt signaling pathways (when NICD binds to Wnt)
[46]. Second, PS1 negatively regulates Wnt signaling by interacting with β-catenin to
facilitate β-catenin turnover in vitro [47–49]. β-catenin signaling is required for normal
cardiac growth and development [50]. Moreover, the PSEN1-E318G and PSEN1-D333G
mutations found in DCM patients [4, 5], are positioned in a large cytoplasmic loop between
transmembrane domains six and seven, with which PS1 binds β-catenin [51].
We showed that overexpression of dPsn by Sd-GAL4 in wing disc results in severe
malformation in wing development accompanied by reduced expression of wg. These data
further support the contention that presenilin negatively regulates Wnt signaling. The Notch
signaling pathway plays important roles in the patterning and differentiation of the wing
veins [35]. Overexpression of dPsn by Ptc-GAL4 led to severe loss of intervein cells and
formation of extra vein; in contrast, silencing of dPsn resulted in normal intervein cells but
loss of acv vein. Given the known role of presenilins in γ-secretase complex [1],
overexpression of dPsn may elevate γ-secretase activity resulting in enhanced NICD release,
thereby potentiating Notch signaling to inhibit intervein cell development but promote vein
cell. Conversely, silencing of dPsn may cause wing vein loss due to reduced γ-secretase
activity. Mutations in presenilins alter the proteolytic processing of amyloid precursor
protein by aberrant γ-secretase activities that results in increased neurotoxic Aβ42
production [8]. However, neither DCM-associated PSEN2-R62H nor PSEN2-S130L
mutation engender significant effects on Aβ42 levels or the Aβ42/40 ratio in vitro [52]. In
addition, treating WT mice with γ–secretase inhibitor DAPT did not alter cardiac function,
including HR, left ventricle systolic and diastolic pressure [36]. These data suggest that the
presenilins may regulate cardiac function through other mechanisms in addition to their
effect on γ-secretase activity. Based on the previous and current findings, we propose that
mutations in PSEN1 and PSEN2 may alter Wnt signaling via β-catenin interaction and NICD
inhibitory crosstalk to ultimately cause defects in cardiac function leading to DCM
pathogenesis.
In summary, we have demonstrated that either the loss or gain of dPsn levels in heart, results
in cardiac dysfunction, owing to aberrant calcium channel receptor activities and disrupted
Wnt signaling transduction. Together, these data provide novel in vivo evidence for
pathological role(s) of the presenilins in DCM pathogenesis.
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Fig. 1.
Representative M-mode optical coherence tomography (OCT) imaging of cardiac function
in 30-day old adult Drosophila. A: Control showed normal heart rate (HR): 250 beat per
minute (BPM) and rhythm; B. Overexpression of dPsn led to increased HR (296BPM) and
irregular heartbeats; C: Silencing of dPsn caused reduced HR (167BPM), small heart
chamber and irregular heartbeat.
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Fig. 2.
Scatter plots of heart rate (HR), end-systolic vertical dimension (ESD) and end-diastolic
vertical dimension (EDD), respectively, of flies in each tested group, generated using a SAS
GLM program. A. HR (beat per minute, BPM); B: ESD (μm); C: EDD (μm). Mean ± SE for
each tested group is shown.
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Fig. 3.
Transmission electron microscopy of the myofibril. A: Controls showed normal myofibril
structure; B: Overexpression of dPsn led to loss of regular structure with vacuoles, a
broadening of Z-line and swollen mitochondria in myofibril; C: Silencing of dPsn caused an
overall decrease in the density of myofibrils with vacuoles, a breaking Z-line, and severely
degenerative mitochondria with impaired structure in myofibril. Magnification: Left:
10,000X, Scale bar: 2μm. Right: 30,000X, Scale bar: 500nm.
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Fig. 4.
Western Blotting by anti-dPsn detected dPsn –C-terminal fragment (CTF) (25 KDa) in the
heart and muscle of controls and transgenic flies in which dPsn was silenced or
overexpressed. The dPsn expression level was normalized with respect to dActin (42KDa)
loading control. Silencing of dPsn led to a 60% decrease in dPsn expression, and
overexpression of dPsn led to a 180% increase in dPsn expression as compared to controls.
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Fig. 5.
Quantification of relative Drosophila inositol 1,4,5-trisphosphate receptor (dIP3R), the
ryanodine receptor (dRyR) and the SR Ca2+-ATPase pump SERCA2a (dSERCA) expression
by real-time PCR using SYBR Green. A: dIP3R: overexpression of dPsn increased dIP3R
level 1.17-fold; silencing of dPsn increased dIP3R expression 2.19-fold. B: dRyR:
overexpression of dPsn decreased dRyR expression to 60%; silencing of dPsn increased
dRyR expression 1.05-fold. C: dSERCA: overexpression of dPsn increased dSERCA level
1.1-fold; silencing of dPsn decreased dSERCA expression to 40%. Results are shown as
Mean ± Std of repeated experiments. Asterisks (*) denote results with p<0.05 compared to
control levels.
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Fig. 6.
Overexpression or silencing of dPsn in the wing. A. B. C. Control flies had normal wings
(A), and wg expression (B) on normal wing disc (C). D. E. F. Overexpression of dPsn in the
wing disc by Sd-GAL4 led to complete loss of both wings (D) and moderately decreased wg
expression (E) on a thinner and smaller wing disc (F). G. Control fly wings have five
longitudinal (L1-5) and two cross-veins: anterior (acv) and posterior (pcv), creating distinct
intervein sectors. H. Overexpression of dPsn in the wing by Ptc-GAL4 led to loss of
intervein cells between L3 and L4 vein. The intervein sector between L4 and L5 was
enlarged and pcv vein was extended. I. silencing of dPsn in the wing by Ptc-GAL4 led to
loss of acv vein in the intervein sector between L3 and L4 vein.
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